
Michael Joshua Ostacher MD MPH, MMSc
Addiction, Psychopharmacology
Professor, Department of Psychiatry and Behavioral Sciences, Stanford University
Join to View Full Profile
VA Palo Alto HCS3801 Miranda Ave 151TPalo Alto, CA 94304
Phone+1 650-493-5000
Fax+1 888-256-2894
Dr. Ostacher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Harvard Medical SchoolM.M.Sc, 2010
- Harvard Medical School Cambridge Health Alliance1996 - 1997
- Harvard Medical School Cambridge HospitalPublic Psychiatry, 1992 - 1994
- Harvard School of Public HealthM.P.H, 1994
- Cambridge Health AllianceResidency, Psychiatry, 1989 - 1992
- Cambridge Health AllianceInternship, Transitional Year, 1988 - 1989
- Vanderbilt University School of MedicineClass of 1988, MD
- Wesleyan UniversityB.A, Honors in the College of Letters, 1978 - 1982
Certifications & Licensure
- CA State Medical License 2009 - 2025
- MA State Medical License 1990 - 2011
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
- American Board of Preventive Medicine Addiction Medicine
Awards, Honors, & Recognition
- Scholars in Clinical Science Program Harvard Medical School, 2008
- Honors in the College of Letters Wesleyan University, Middletown, Connecticut, 1982
Clinical Trials
- Lithium for Suicidal Behavior in Mood Disorders Start of enrollment: 2015 Jul 08
- Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder Start of enrollment: 2017 Apr 03
- Investigation of the Freespira Breathing System in the Treatment of Post Traumatic Stress Disorder (PTSD) Start of enrollment: 2017 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsMaking Progress in Clinical Trials for Suicide Prevention: A Review.Samuel T Wilkinson, Craig J Bryan, Larry D Alphs, Carla M Canuso, Michael J Ostacher
JAMA Psychiatry. 2025-04-01 - Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.Derek D Satre, Dhweeja Dasarathy, Steven L Batki, Michael J Ostacher, Hannah R Snyder
Alimentary Pharmacology & Therapeutics. 2025-02-01 - 3 citationsSingle-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.Sara Ellis, Catherine Bostian, Wendy Feng, Eileen Fischer, Garrett Schwartz
Journal of Affective Disorders. 2025-01-15
Journal Articles
- Management of Posttraumatic Stress DisorderMichael J Ostacher, Adam S Cifu, JAMA
- Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).Bowden CL, Perlis RH, Thase ME, Ketter TA, Ostacher MM, Calabrese JR, Reilly-Harrington NA, Gonzalez JM, Singh V, Nierenberg AA, Sachs GS, CNS Neurosci Ther
- Bipolar and substance use disorder comorbidity: Diagnostic and treatment considerations.Ostacher MJ, Focus
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The Impact of Caffeine, Nicotine, and Alcohol on Outcome in Bipolar Disorder: A STEP-BD Examination.Ostacher MJ, Hoblyn J, Perlis RH, Society of Biological Psychiatry, Philadelphia, PA
- STEP-BD: lessons learned, outcomes and directions.Ostacher MJ, Society of Biological Psychiatry's 65th Annual Meeting, New Orleans, LA
- Neuropsychological functioning in patients with bipolar disorder with and without a history of substance use disorders.Ostacher MJ, Nierenberg AA, Perlis RH, Deckersbach T, 48th American College of Neuropsychopharmacology Annual Meeting, Hollywood, FL
- Join now to see all
Lectures
- Rethinking comorbid substance use disorders in bipolar disorder.The 160th American Psychiatric Association Annual Meeting, San Diego, CA
- How do you know if the medication is working in patients with bipolar disorder?The 162nd American Psychiatric Association Meeting, San Francisco, CA
- Do a few drinks really matter?: the impact of drugs and alcohol in bipolar disorder.Grand Rounds, Temple University School of Medicine. Philadelphia, PA.
- Join now to see all
Press Mentions
- Can a Monthly Injection Be the Key to Curbing Addiction? These Experts Say YesMay 6th, 2022
- MGH Psychiatry Explains Bipolar Disorder to Probation OfficersApril 10th, 2009
- The Case for MDMA's Approval Is Riddled with ProblemsJune 7th, 2024
Committees
- Co-Chair, Bipolar Disorder Task Group, National Network of Depression Centers 2012 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: